Paper40211585
Ovarian Function Restoration with Biomimetic Scaffold Incorporating Angiogenic Molecules and Antioxidant in Chemotherapy-Induced Perimenopausal Model.
Kim DS and 8 others. Adv Healthc Mater, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Ovarian Function Restoration with Biomimetic Scaffold Incorporating Angiogenic Molecules and Antioxidant in Chemotherapy-Induced Perimenopausal Model. Papers, record 40211585. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40211585
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ovarian Function Restoration with Biomimetic Scaffold Incorporating Angiogenic Molecules and Antioxidant in Chemotherapy-Induced Perimenopausal Model.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antioxidants | Major topic |
| Primary Ovarian Insufficiency | Major topic |
| Ovary | Major topic |
| Tissue Scaffolds | Major topic |
| Perimenopause | Major topic |
| Biomimetic Materials | Major topic |
| Antineoplastic Agents | Major topic |
| Female | |
| Animals | |
| Mice | |
| Humans | |
| Disease Models, Animal | |
| Mesenchymal Stem Cells | |
| Melatonin | |
| Human Embryonic Stem Cells |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| National Research Foundation of Korea | PubMed | |||
| 2023R1A2C3003807 | Korean government | PubMed | ||
| Korean Fund for Regenerative Medicine | PubMed | |||
| 23A0206L1 | Ministry of Science and ICT, the Ministry of Health & Welfare | PubMed |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36696086 | Exosomes Derived from Human Amniotic Mesenchymal Stem Cells Facilitate Diabetic Wound Healing by Angiogenesis and Enrich Multiple lncRNAs. | Tissue Eng Regen Med | 2023 | https://conductscience.org/library/papers/36696086 | PubMed |
| 2 | 29168173 | The role of melatonin on chemotherapy-induced reproductive toxicity. | J Pharm Pharmacol | 2018 | https://conductscience.org/library/papers/29168173 | PubMed |
| 3 | 38140076 | Smart Responsive and Controlled-Release Hydrogels for Chronic Wound Treatment. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/38140076 | PubMed |
| 4 | 36451687 | Osteogenesis in the presence of chemotherapy: A biomimetic approach. | J Tissue Eng | 2022 | https://conductscience.org/library/papers/36451687 | PubMed |
| 5 | 38029018 | A bioengineered in situ ovary (ISO) supports follicle engraftment and live-births post-chemotherapy. | J Tissue Eng | 2023 | https://conductscience.org/library/papers/38029018 | PubMed |
| 6 | 5715685 | Proposal for a classification of oocytes and follicles in the mouse ovary. | J Reprod Fertil | 1968 | https://conductscience.org/library/papers/5715685 | PubMed |
| 7 | 36555999 | Protective Effect and Mechanism of Melatonin on Cisplatin-Induced Ovarian Damage in Mice. | J Clin Med | 2022 | https://conductscience.org/library/papers/36555999 | PubMed |
| 8 | 36969699 | Multi-modulation of immune-inflammatory response using bioactive molecule-integrated PLGA composite for spinal fusion. | Mater Today Bio | 2023 | https://conductscience.org/library/papers/36969699 | PubMed |
| 9 | 36892736 | Tissue-Engineered 3D In Vitro Disease Models for High-Throughput Drug Screening. | Tissue Eng Regen Med | 2023 | https://conductscience.org/library/papers/36892736 | PubMed |
| 10 | 37744287 | Biological therapies for premature ovarian insufficiency: what is the evidence? | Front Reprod Health | 2023 | https://conductscience.org/library/papers/37744287 | PubMed |
| 11 | 28868235 | Design of Injectable Materials to Improve Stem Cell Transplantation. | Curr Stem Cell Rep | 2016 | https://conductscience.org/library/papers/28868235 | PubMed |
| 12 | 31093291 | Challenges and Controversies in Human Mesenchymal Stem Cell Therapy. | Stem Cells Int | 2019 | https://conductscience.org/library/papers/31093291 | PubMed |
| 13 | 35510605 | Engineering biomaterials to 3D-print scaffolds for bone regeneration: practical and theoretical consideration. | Biomater Sci | 2022 | https://conductscience.org/library/papers/35510605 | PubMed |
| 14 | 31675495 | Cellular Senescence: Defining a Path Forward. | Cell | 2019 | https://conductscience.org/library/papers/31675495 | PubMed |
| 15 | 33303971 | Vascular remodeling by placenta-derived mesenchymal stem cells restores ovarian function in ovariectomized rat model via the VEGF pathway. | Lab Invest | 2021 | https://conductscience.org/library/papers/33303971 | PubMed |
| 16 | 25859241 | Hypothalamic-pituitary-gonadal axis involvement in learning and memory and Alzheimer's disease: more than "just" estrogen. | Front Endocrinol (Lausanne) | 2015 | https://conductscience.org/library/papers/25859241 | PubMed |
| 17 | 33045417 | Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: a prospective randomized, placebo-controlled 36-month study of safety and efficacy. | Spine J | 2021 | https://conductscience.org/library/papers/33045417 | PubMed |
| 18 | 35137550 | Medical Applications of Porous Biomaterials: Features of Porosity and Tissue-Specific Implications for Biocompatibility. | Adv Healthc Mater | 2022 | https://conductscience.org/library/papers/35137550 | PubMed |
| 19 | 37507801 | Restoration of dysregulated intestinal barrier and inflammatory regulation through synergistically ameliorating hypoxia and scavenging reactive oxygen species using ceria nanozymes in ulcerative colitis. | Biomater Res | 2023 | https://conductscience.org/library/papers/37507801 | PubMed |
| 20 | 36732629 | Landscape of pathogenic mutations in premature ovarian insufficiency. | Nat Med | 2023 | https://conductscience.org/library/papers/36732629 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42196335 | Synergistic Regenerative Strategies: Combining Polydeoxyribonucleotide with Biochemical and Physical Agents. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196335 | PubMed |
| 41286389 | Protective Effect of Glutathione Supplementation On Mouse Ovarian Tissue Vitrification and Autologous Transplantation. | Reprod Sci | 2026 | https://conductscience.org/library/papers/41286389 | PubMed |
| 41206517 | Female fertility preservation: 25 years of progress, expanding indications and future prospects. | Hum Reprod Update | 2026 | https://conductscience.org/library/papers/41206517 | PubMed |
| 40565167 | Comparative Analysis of Melatonin and Polydeoxyribonucleotide: Possible Benefits of Co-Treatment Effects and Potential Synergistic Applicability. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565167 | PubMed |
| 40211585 | Ovarian Function Restoration with Biomimetic Scaffold Incorporating Angiogenic Molecules and Antioxidant in Chemotherapy-Induced Perimenopausal Model. | Adv Healthc Mater | 2025 | https://conductscience.org/library/papers/40211585 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40211585
GET https://conductscience.org/api/papers/v1/40211585/references?page=2